Literature DB >> 20690182

Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells.

Federico Simonetta1, Amel Chiali, Corinne Cordier, Alejandra Urrutia, Isabelle Girault, Stéphane Bloquet, Corinne Tanchot, Christine Bourgeois.   

Abstract

Regulatory T cells (Treg) are commonly identified by CD25 (IL-2R alpha) surface expression and/or intracellular expression of the FOXP3 transcription factor. In addition, Treg are also characterized by low CD127 (IL-7R alpha) expression when compared to conventional T cells and their biology in the periphery is considered essentially independent of IL-7. We further investigated CD127 expression on Treg and we demonstrated differential CD127 expression depending on Treg subsets considered. Notably, we observed high CD127 expression on inducible costimulatory molecule (ICOS)- and CD103-expressing Treg subsets. Since these two markers reflect activation status, we addressed whether Treg activation modulated CD127 expression. We demonstrated that in contrast to conventional T cells, Treg significantly upregulated CD127 expression during in vitro and in vivo activation using adoptive transfer and contact dermatitis models. High CD127 expression on Treg was also predominantly detected ex vivo in some specific sites, notably bone marrow and skin. Importantly, higher CD127 expression on Treg correlated with higher phosphorylation of STAT5 upon IL-7 exposure. High CD127 expression on Treg also provided survival advantage upon in vitro incubation with IL-7. We thus demonstrated that low CD127 expression is not an intrinsic characteristic of Treg and we identified activated Treg as a potential target of endogenous or therapeutic IL-7.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20690182     DOI: 10.1002/eji.201040531

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  64 in total

Review 1.  Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

2.  The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.

Authors:  Antonio Curti; Roberto M Lemoli; Giulia Tolomelli; Katia Mancuso; Paola Tacchetti; Francesca Patriarca; Monica Galli; Lucia Pantani; Beatrice Zannetti; Maria Rosa Motta; Simonetta Rizzi; Elisa Dan; Barbara Sinigaglia; Valeria Giudice; Andrea Olmo; Mario Arpinati; Gabriella Chirumbolo; Renato Fanin; Russell E Lewis; Laura Paris; Francesca Bonifazi; Michele Cavo
Journal:  Bone Marrow Transplant       Date:  2019-11-25       Impact factor: 5.483

3.  Regulatory T cells and Atherosclerosis.

Authors:  Jahaira Lopez Pastrana; Xiaojin Sha; Anthony Virtue; Jietang Mai; Ramon Cueto; In Ae Lee; Hong Wang; Xiao-Feng Yang
Journal:  J Clin Exp Cardiolog       Date:  2012-10-08

Review 4.  The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention.

Authors:  Joanna Domagala-Kulawik
Journal:  Transl Lung Cancer Res       Date:  2015-04

Review 5.  Interleukin-2, Interleukin-7, T cell-mediated autoimmunity, and N-glycosylation.

Authors:  Ani Grigorian; Haik Mkhikian; Michael Demetriou
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

6.  Differential response of regulatory and conventional CD4⁺ lymphocytes to CD3 engagement: clues to a possible mechanism of anti-CD3 action?

Authors:  Li Li; Junko Nishio; André van Maurik; Diane Mathis; Christophe Benoist
Journal:  J Immunol       Date:  2013-08-28       Impact factor: 5.422

7.  The regulatory T cells in anti-influenza antibody response post influenza vaccination.

Authors:  Shih-Min Wang; Ming-Hsun Tsai; Huan-Yao Lei; Jen-Ren Wang; Ching-Chuan Liu
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

8.  CD31, a Valuable Marker to Identify Early and Late Stages of T Cell Differentiation in the Human Thymus.

Authors:  Marc Douaisi; Rachel S Resop; Maho Nagasawa; Joshua Craft; Beth D Jamieson; Bianca Blom; Christel H Uittenbogaart
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

Review 9.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

10.  CD2-mediated regulation of peripheral CD4(+)  CD25(+) regulatory T-cell apoptosis accompanied by down-regulation of Bim.

Authors:  Yuji Kashiwakura; Daisuke Sakurai; Yumiko Kanno; Masaaki Hashiguchi; Ayano Kobayashi; Akira Kurosu; Shogo Tokudome; Tetsuji Kobata; Hidefumi Kojima
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.